These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28504927)

  • 1. Mechanisms of quinolone action and resistance: where do we stand?
    Correia S; Poeta P; Hébraud M; Capelo JL; Igrejas G
    J Med Microbiol; 2017 May; 66(5):551-559. PubMed ID: 28504927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of drug resistance: quinolone resistance.
    Hooper DC; Jacoby GA
    Ann N Y Acad Sci; 2015 Sep; 1354(1):12-31. PubMed ID: 26190223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.
    Hooper DC; Jacoby GA
    Cold Spring Harb Perspect Med; 2016 Sep; 6(9):. PubMed ID: 27449972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-mediated quinolone resistance.
    Jacoby GA; Strahilevitz J; Hooper DC
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 25584197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of and resistance to quinolones.
    Fàbrega A; Madurga S; Giralt E; Vila J
    Microb Biotechnol; 2009 Jan; 2(1):40-61. PubMed ID: 21261881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of virulence genes and role of gyrA mutations in quinolone resistant and susceptible strains of Salmonella Weltevreden and Newport isolated from seafood.
    Deekshit VK; Kumar BK; Rai P; Karunasagar I; Karunasagar I
    J Appl Microbiol; 2015 Oct; 119(4):970-80. PubMed ID: 26249136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of quinolone action and resistance.
    Aldred KJ; Kerns RJ; Osheroff N
    Biochemistry; 2014 Mar; 53(10):1565-74. PubMed ID: 24576155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae: a multicenter study].
    Coban AY; Nohut OK; Tanrıverdi Çaycı Y; Bayramoğlu G; Pirinççiler M; Cetinkaya E; Cekiç Cihan C; Bozdoğan B; Durupınar B
    Mikrobiyol Bul; 2012 Jul; 46(3):366-74. PubMed ID: 22951649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms associated with quinolone resistance in Enterobacteriaceae: review and update.
    Azargun R; Gholizadeh P; Sadeghi V; Hosainzadegan H; Tarhriz V; Memar MY; Pormohammad A; Eyvazi S
    Trans R Soc Trop Med Hyg; 2020 Oct; 114(10):770-781. PubMed ID: 32609840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J; Hooper DC
    Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates.
    Ostrer L; Khodursky RF; Johnson JR; Hiasa H; Khodursky A
    Int J Antimicrob Agents; 2019 Mar; 53(3):318-324. PubMed ID: 30582984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of and resistance to quinolones.
    Bearden DT; Danziger LH
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):224S-232S. PubMed ID: 11642689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of quinolone action and microbial response.
    Hawkey PM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():29-35. PubMed ID: 12702701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of plasmid-mediated resistance to quinolones].
    Rodríguez-Martínez JM
    Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):25-31. PubMed ID: 15701330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quinolones. Nowadays perspectives and mechanisms of resistance].
    Álvarez-Hernández DA; Garza-Mayén GS; Vázquez-López R
    Rev Chilena Infectol; 2015 Oct; 32(5):499-504. PubMed ID: 26633105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolone resistance mechanisms in pneumococci.
    Eliopoulos GM
    Clin Infect Dis; 2004 May; 38 Suppl 4():S350-6. PubMed ID: 15127369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV.
    Badshah SL; Ullah A
    Eur J Med Chem; 2018 May; 152():393-400. PubMed ID: 29751233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity.
    Naeem A; Badshah SL; Muska M; Ahmad N; Khan K
    Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms.
    Li XZ
    Int J Antimicrob Agents; 2005 Jun; 25(6):453-63. PubMed ID: 15890498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
    Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.